UNITED PAYORS & UNITED PROVIDERS INC
10-Q, 1997-11-13
SERVICES, NEC
Previous: POST APARTMENT HOMES LP, 10-Q, 1997-11-13
Next: CHARTER COMMUNICATIONS SOUTHEAST LP, 10-Q, 1997-11-13



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q


              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 1997

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

              For the transition period from             to
                                            ----------     ---------

                         Commission File Number 0-20905
                                                -------

                     UNITED PAYORS & UNITED PROVIDERS, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

            Delaware                                 51-0374698
  -------------------------------     ---------------------------------------
  (State or other jurisdiction of     (I.R.S. Employer Identification Number)
  incorporation or organization)


          2275 Research Boulevard, 6th Floor, Rockville, Maryland 20850
          -------------------------------------------------------------
               (Address of principal executive offices, Zip Code)

                                 (301) 548-1000
                ------------------------------------------------
                (Registrant's phone number, including area code)

                                 Not Applicable
              ----------------------------------------------------
              (Former name, former address and former fiscal year,
                          if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.    Yes   X      No
                                          -----       -----

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date.

The number of shares of common stock, par value $.01 per share, outstanding on
November 3, 1997 was 11,385,786.


<PAGE>



                     United Payors & United Providers, Inc.
                                and Subsidiaries

                          Third Quarter 1997 Form 10-Q

                                TABLE OF CONTENTS


                                                                          Page
PART I FINANCIAL INFORMATION

  ITEM 1. Financial Statements

      Consolidated Balance Sheets as of September 30, 1997 and
      December 31, 1996 (Unaudited).........................................1

      Consolidated Statements of Operations for the Three and Nine Months
      Ended September 30, 1997 and 1996 (Unaudited).........................2

      Consolidated Statements of Cash Flows for the Nine Months Ended
      September 30, 1997 and 1996 (Unaudited)...............................3

      Notes to Consolidated Financial Statements............................4


   ITEM 2. Management's Discussion and Analysis of Financial
           Condition and Results of Operations..............................6


PART II OTHER INFORMATION


SIGNATURES






<PAGE>



PART I.  FINANCIAL INFORMATION
ITEM 1.  FINANCIAL STATEMENTS
                                    UNITED PAYORS & UNITED PROVIDERS, INC.
                                         CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                          September 30,   December 31,
                                                                               1997           1996
                                                                          -------------   ------------
<S>                                                                       <C>             <C>

                                                 ASSETS                    (Unaudited)
Current assets:
   Cash and cash equivalents                                               $  7,513,131   $ 16,034,184
   Short-term investments                                                    11,418,464     10,448,564
   Accounts receivable                                                       10,939,768      8,108,015
   Other current assets                                                         689,268        570,222
                                                                          -------------   ------------
      Total current assets                                                   30,560,631     35,160,985
                                                                          -------------   ------------

Fixed assets, net                                                             3,955,589      2,782,601
Advances to contracting providers, net                                       14,285,989      4,300,730
Investments                                                                   1,791,045      1,079,354
Intangible and other assets, net                                             24,632,424      9,924,253
                                                                          -------------   ------------
      Total assets                                                         $ 75,225,678   $ 53,247,923
                                                                          =============   ============

                                     LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
   Accounts payable and accrued expenses                                   $  6,000,205   $  5,758,025
   Income and other taxes payable                                             1,193,851        958,991
   Notes payable and capital lease                                            2,141,675        330,912
   Other current liabilities                                                  1,993,849             --
                                                                          -------------   ------------
      Total current liabilities                                              11,329,580      7,047,928
Non-current liabilities                                                       1,510,000        700,000
Notes payable and capital lease, less current portion                         8,145,760        324,281
                                                                          -------------   ------------
      Total liabilities                                                      20,985,340      8,072,209
                                                                          -------------   ------------

Commitments and contingencies

Stockholders' equity:
   Convertible preferred stock, $0.01 par value, 5,000,000 shares
      authorized, none issued and outstanding at September 30,
      1997 and December 31, 1996                                                     --             --
   Common stock, $0.01 par value, 35,000,000 shares authorized,
      11,573,636 shares issued at September 30, 1997 and
      December 31, 1996, respectively                                           115,736        115,736
   Additional paid-in capital                                                37,096,405     35,154,820
   Deferred compensation                                                     (1,218,500)            --
   Retained earnings                                                         20,724,540      9,935,158
   Less treasury stock, 188,750 shares at September 30, 1997 and
      22,500 shares at December 31, 1996, at cost                            (2,477,843)       (30,000)
                                                                          -------------   ------------
      Total stockholders' equity                                             54,240,338     45,175,714
                                                                          -------------   ------------

      Total liabilities and stockholders' equity                           $ 75,225,678   $ 53,247,923
                                                                          =============   ============
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                        1

<PAGE>



                     UNITED PAYORS & UNITED PROVIDERS, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)



<TABLE>
<CAPTION>
                                  Three Months Ended September 30,     Nine Months Ended September 30,
                                  --------------------------------     -------------------------------
                                         1997           1996                 1997           1996
                                     ------------   ------------         ------------   ------------
<S>                                  <C>            <C>                  <C>            <C>
Provider network revenue             $ 10,346,719   $  7,735,916         $ 27,892,819   $ 22,974,611
Utilization management                  4,910,284             --           14,687,599             --
                                     ------------   ------------         ------------   ------------
     Total revenue                     15,257,003      7,735,916           42,580,418     22,974,611
                                     ------------   ------------         ------------   ------------

Operating expenses:
   Direct contract expenses             7,380,199      3,033,236           20,295,786      9,266,945
   General and administrative           1,559,002        711,358            4,578,512      1,356,317
   Depreciation and amortization          431,690         87,395            1,087,821        228,741
                                     ------------   ------------         ------------   ------------
     Total operating expenses           9,370,891      3,831,989           25,962,119     10,852,003
                                     ------------   ------------         ------------   ------------

Operating income                        5,886,112      3,903,927           16,618,299     12,122,608

Other income, net                         791,976        410,052            1,490,270        540,841
                                     ------------   ------------         ------------   ------------

Income before income taxes              6,678,088      4,313,979           18,108,569     12,663,449

Income tax provision                   (2,699,535)    (1,712,000)          (7,319,108)    (5,052,000)
                                     ------------   ------------         ------------   ------------

Net income                           $  3,978,553   $  2,601,979         $ 10,789,461   $  7,611,449
                                     ============   ============         ============   ============

Net income per share                 $       0.34   $       0.22         $       0.92   $       0.79
                                     ============   ============         ============   ============

Shares used in computing net income
      per common share outstanding     11,783,762     11,334,308           11,683,582      9,650,940
                                     ============   ============         ============   ============
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                        2

<PAGE>


                     UNITED PAYORS & UNITED PROVIDERS, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                       Nine Months Ended September 30,
                                                             1997            1996
                                                        -------------  --------------
<S>                                                      <C>            <C>
Operating activities
   Net income                                            $ 10,789,461   $  7,611,449
   Adjustment to reconcile net income to
   net cash provided by (used in) operations
      Depreciation and amortization                         1,087,821        228,741
      Loss on sale of fixed assets                            143,138             --
      Deferred income taxes and other non-cash items          435,127        526,206
      Changes in reserves and allowances                      114,741             --
      Changes in assets and liabilities, net of effects
        from acquisition in 1997:
        Accounts receivable                                (1,273,099)    (4,805,952)
        Accounts payable and accrued expenses                (920,306)      (393,407)
        Current and other assets                              101,718       (423,556)
        Income taxes payable                                  109,898       (191,300)
                                                         ------------   ------------
   Net cash provided by operating activities               10,588,499      2,552,181
                                                         ------------   ------------

Investing activities
      Purchases of fixed assets                            (1,335,478)      (510,326)
      Proceeds from sale of fixed assets                       37,305             --
      Purchases of short-term investments                 (16,011,644)    (4,298,917)
      Proceeds from sale of short-term investments         15,357,623             --
      Advances to contracting providers                   (10,100,000)    (1,529,230)
      Payment for acquisition, net of cash acquired       (13,322,685)            --
      Payments for other investments                         (726,691)      (200,000)
                                                         ------------   ------------
   Net cash used in investing activities                  (26,101,570)    (6,538,473)
                                                         ------------   ------------

Financing activities
      Issuance of capital stock                                    --        150,000
      Net proceeds from initial public offering                    --     26,875,443
      Purchases of treasury stock                          (2,447,843)       (30,000)
      Repayment of loan from stockholder                           --     (3,700,000)
      Proceeds from borrowing                              10,000,000             --
      Repayment of other debt                                (560,139)      (171,781)
                                                         ------------   ------------
   Net cash provided by financing activities                6,992,018     23,123,662
                                                         ------------   ------------

Increase (decrease) in cash and cash equivalents           (8,521,053)    19,137,370
Cash and cash equivalents
      Beginning of the period                              16,034,184      8,701,135
                                                         ------------   ------------
      End of the period                                  $  7,513,131   $ 27,838,505
                                                         ============   ============
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                        3

<PAGE>



                     UNITED PAYORS & UNITED PROVIDERS, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)


1. BUSINESS, ORGANIZATION AND BASIS OF PRESENTATION

     United Payors & United Providers, Inc. ("UP&UP"), a Delaware corporation,
serves as an intermediary between health care payors (e.g., insurance companies)
and health care providers (e.g., hospitals) by entering into contractual
arrangements designed generally to produce cost savings and other benefits for
payors and increased liquidity and improved efficiency in claims submissions for
providers. UP&UP derives its revenue primarily from a portion of the price
concessions offered by the providers under such contractual arrangements.
Effective October 1, 1996, UP&UP acquired National Health Services, Inc.
("NHS"), a national health care utilization management services company. NHS
offers medical utilization management services to insurance underwriters,
self-insured businesses, provider organizations, and others. Such services
include precertification of in-patient and out-patient medical care, and case
management.

     Effective December 31, 1995, UP&UP entered into an agreement with America's
Health Plan, Inc., an indirect wholly-owned subsidiary of Principal Mutual Life
Insurance Company ("Principal Mutual"), whereby specified payor clients
representing approximately 40% of America's Health Plan, Inc.'s revenues for the
year ended December 31, 1995, were transferred to UP&UP. Principal Mutual owns
approximately 38% of the Company's Common Stock. Effective September 1, 1997,
UP&UP acquired the remaining operations of America's Health Plan, Inc.

     America's Health Plan, Inc. develops and markets its proprietary health
care provider network for access by payors of health care costs such as
insurers, third-party administrators and unions. The name of America's Health
Plan, Inc. was changed to UP&UP, Inc. immediately prior to the closing. In
connection with the acquisition, the Company was granted the right to operate
the health care provider network under the name AMERICA'S HEALTH PLAN. UP&UP,
Inc. is hereafter referred to as "AHP". UP&UP, NHS and AHP are hereafter
collectively referred to as "the Company".

2. LEGAL PROCEEDINGS

     Except as discussed below, the Company currently is not a party to any
legal proceedings, nor is it aware of any legal proceedings threatened against
it.

     On April 26, 1996, a civil complaint was filed against the Company in the
United States District Court for the Northern District of Illinois by HealthCare
COMPARE Corporation d/b/a The Affordable Medical Networks ("HealthCare
COMPARE"). The litigation is currently in the discovery phase. HealthCare
COMPARE seeks injunctive and other relief, including possible damages, based
generally on allegations that representatives of the Company, in at least four
instances, made various misrepresentations to prospective contracting providers,
including to the effect that the Company's provider network was affiliated with
HealthCare COMPARE's provider network or that HealthCare COMPARE had agreed to
utilize the Company's provider network. The Company denies the allegations in
the complaint and believes the complaint by HealthCare COMPARE is without merit.
The Company intends to vigorously defend against the complaint. After
consultation with counsel and review of available facts, management believes
that damages, if any, arising from this litigation will not be material to the
consolidated financial statements of the Company.

     On January 29, 1997, a civil complaint was initiated against America's
Health Plan, Inc. in the United States District Court for the Northern District
of Georgia by AmeriCare Health Alliance of Georgia, L.L.C. ("AmeriCare"), a
health care provider organization. AmeriCare seeks damages for lost profits in
the amount of $10 million, as well as punitive damages, for a breach of a
contract that America's Health Plan, Inc. believes was never formed.
Alternatively, AmeriCare is seeking fraud damages against America's Health Plan,
Inc. for its failure to enter into a contract with the plaintiff. The Company
believes the complaint by AmeriCare is without merit and intends to vigorously
defend against the complaint. After consultation with counsel and review of
available facts, management believes that damages, if any, arising from this
litigation will not be material to the consolidated financial statements of the
Company.

                                        4

<PAGE>



     The Company is also a party to other legal actions arising in the ordinary
course of business. Management believes that damages arising from these actions,
if any, will not be material to the consolidated financial statements of the
Company.

3. BUSINESS COMBINATIONS

     Effective October 1, 1996, UP&UP acquired National Health Services, Inc.
for a purchase price of approximately $7.2 million, consisting of $5.9 million
in cash, warrants to purchase an aggregate of 318,000 shares of the Company's
common stock valued at $1.1 million and the assumption of approximately $200,000
in liabilities in excess of the fair value of the assets acquired. The
acquisition has been accounted for as a purchase and, accordingly, the results
of operations of NHS for the three and nine months ended September 30, 1996 have
not been included in the accompanying consolidated statements of operations of
the Company for those periods. The acquisition resulted in goodwill of $7.2
million which is being amortized over 15 years. Accumulated amortization at
September 30, 1997 amounted to $481,764. The unamortized portion of the goodwill
at September 30, 1997, is included in intangible and other assets in the
accompanying consolidated balance sheet.

     Effective September 1, 1997, UP&UP acquired AHP for a purchase price of
approximately $15.5 million, consisting of $14.9 million in cash and the
assumption of approximately $600,000 in liabilities in excess of the fair value
of the assets acquired. The purchase price may be subject to adjustment through
the year 2001, if AHP revenues exceed pre-determined targets. In connection with
the acquisition, the Company has entered into a loan agreement with a bank for
an aggregate amount of $15 million. The loan bears interest at the rate of LIBOR
plus 112 basis points and is to be repaid in equal quarterly installments over a
period of five years. The acquisition has been accounted for as a purchase and,
accordingly, the results of operations of AHP have been included in the
accompanying consolidated statements of operations since the effective date of
the acquisition. The acquisition resulted in goodwill of approximately $15.5
million which is being amortized over 20 years. The unamortized portion of
goodwill at September 30, 1997, is included in intangible and other assets in
the accompanying consolidated balance sheet.

     The following unaudited pro forma consolidated results of operations for
the nine months ended September 30, 1997 and 1996 are presented as though AHP
had been acquired at the beginning of 1996, after giving effect to purchase
accounting adjustments relating to interest, the amortization of goodwill and
income taxes.

<TABLE>
<CAPTION>
                                                  1997           1996
                                              -----------     -----------
         <S>                                  <C>             <C>
         Revenue                              $51,906,314     $35,696,349
                                              ===========     ===========
         Net income                           $11,764,194     $10,064,050
                                              ===========     ===========
         Net income per share                 $      1.01     $      1.04
                                              ===========     ===========
         Weighted average shares outstanding   11,683,582       9,650,940
                                              ===========     ===========
</TABLE>

     The pro forma results of operations are not necessarily indicative of the
results that would have occurred had the AHP acquisition been consummated as of
January 1, 1996, nor are they necessarily indicative of future operating
results.

4. RECLASSIFICATIONS

     Certain amounts in the financial statements for the quarters ended
September 30, 1996 and March 31, 1997 have been reclassified to conform to the
presentation of the financial statements for the quarter ended September 30,
1997.

5. EARNINGS PER SHARE

     In February 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 128, Earnings Per Share, effective for
financial statements for both interim and annual periods ending after December
15, 1997. This Statement replaces the existing calculation and presentation of
primary and fully diluted earnings per share with basic and diluted earnings per
share. This change is not expected to have a material effect on the Company's
earnings per share.

                                        5

<PAGE>



6. UNAUDITED INFORMATION

     The consolidated financial statements for the three and nine months ended
September 30, 1997 and 1996 have not been audited but, in the opinion of
management, include all adjustments (consisting only of normal recurring
accruals) necessary to present fairly the information set forth therein. The
results of operations for the three and nine months ended September 30, 1997 and
1996 are not necessarily indicative of the results to be expected for the full
year or in the future.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
        RESULTS OF OPERATIONS

     This Form 10-Q may contain forward-looking statements (see "Certain Factors
That May Affect Future Operating Results or Stock Prices") within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements involve a number of risks and uncertainties. The
Company undertakes no obligation to revise any forward-looking statements in
order to reflect events or circumstances that may arise after the date of this
report. Readers are urged to carefully review and consider the various
disclosures made by the Company in this report and in the Company's other
filings with the Securities and Exchange Commission that attempt to advise
interested parties of the risks and factors that may affect the Company's
business.

GENERAL

     United Payors & United Providers, Inc. ("UP&UP"), a Delaware corporation,
serves as an intermediary between health care payors (e.g., insurance companies)
and health care providers (e.g., hospitals) by entering into contractual
arrangements designed generally to produce cost savings and other benefits for
payors ("Payor Clients") and increased liquidity and improved efficiency in
claims submissions for providers ("Contracting Providers"). UP&UP derives its
revenue primarily from a portion of the price concessions offered by the
providers under such contractual arrangements. Effective October 1, 1996, UP&UP
acquired National Health Services, Inc. ("NHS"), a national health care
utilization management services company. NHS offers medical utilization
management services to insurance underwriters, self-insured businesses, provider
organizations, and others. Such services include precertification of in-patient
and out-patient medical care, and case management. The acquisition has been
accounted for as a purchase and, accordingly, the consolidated results of
operations of the Company for the three and nine months ended September 30, 1996
do not include the results of operations of NHS for those periods.

     Effective December 31, 1995, UP&UP entered into an agreement with America's
Health Plan, Inc., an indirect wholly-owned subsidiary of Principal Mutual Life
Insurance Company ("Principal Mutual"), whereby specified payor clients
representing approximately 40% of America's Health Plan, Inc.'s revenues for the
year ended December 31, 1995, were transferred to UP&UP. Under the terms of the
agreement, the transferred payor clients have continued to access America's
Health Plan, Inc.'s proprietary health care provider network. Principal Mutual
owns approximately 38% of the Company's Common Stock. Effective September 1,
1997, UP&UP acquired the remaining operations of America's Health Plan, Inc.

     America's Health Plan, Inc. develops and markets its proprietary health
care provider network for access by payors of health care costs such as
insurers, third-party administrators and unions. The name of America's Health
Plan, Inc. was changed to UP&UP, Inc. immediately prior to the closing. In
connection with the acquisition, the Company was granted the right to operate
the health care provider network under the name AMERICA'S HEALTH PLAN. UP&UP,
Inc. is hereafter referred to as "AHP". UP&UP, NHS and AHP are hereafter
collectively referred to as "the Company".

REVENUE

     Provider network revenues are influenced by, among other variables: (i) the
number of Contracting Providers and Payor Clients; (ii) the volume of claims
submitted by Contracting Providers to Payor Clients; (iii) the amount of price
concessions the Company negotiates with Contracting Providers; and (iv) the
contractual price concession sharing arrangements negotiated by the Company with
Payor Clients. In effect, these variables correspond to breadth (number of
Contracting Providers and Payor Clients), volume (claims per period) and depth
(amount of price concession), all of which define savings and the Company's
resultant revenues.

                                        6

<PAGE>



     Medical utilization management services revenues are based on contractual
arrangements. Contracts may reflect a capitated rate, fee for service or hourly
rate. Precertification revenues are generally based on monthly capitation
calculations. Case management revenues are generally based on fee for service or
hourly rates.

DIRECT CONTRACT EXPENSES

     Direct contract expenses include access fees paid by UP&UP and AHP for the
utilization of other provider networks, marketing commissions, and other direct
costs of services such as personnel related to repricing of claims, client
services, and other costs incurred in connection with the generation of revenue
and the development of the Company's provider network. NHS direct contract
expenses include the costs of medical personnel (nurses and doctors) and other
expenses related to administering its contracts.

Marketing commissions are payable to consultants who became entitled to such
commissions for their role in obtaining contracts with certain Payor Clients.

GENERAL AND ADMINISTRATIVE EXPENSES

     General and administrative expenses include salaries and related costs for
personnel involved in the administration of the Company and other costs such as
professional services and general overhead expenses.

RESULTS OF OPERATIONS

Three Months Ended September 30, 1997 Compared to Three Months Ended
September 30, 1996

     Provider network revenue increased by $2.6 million, from $7.7 million in
1996 to $10.3 million in 1997. Of this increase, $1.6 million was attributable
to the addition of new Payor Clients, the growth in the overall claims volume
from existing Payor Clients and the expansion of the UP&UP provider network. The
remainder of the increase was attributable to the acquisition of AHP. At
September 30, 1997 the provider network consisted of approximately 5,600
Contracting Providers compared to approximately 1,900 Contracting Providers at
September 30, 1996. Utilization management services revenue of $4.9 million in
1997 represents the revenue of NHS which was acquired effective October 1, 1996.

     Direct contract expenses increased by $4.4 million, from $3.0 million in
1996 to $7.4 million in 1997. Access fees to other provider networks as a
percentage of provider network revenue were 18.6% ($1.4 million) in 1996
compared to 10.5% ($1.1 million) in 1997. This decrease was attributable to the
growth in the number of providers contracting directly with UP&UP, Payor Clients
accessing more direct contracts and the negotiation of lower rates in agreements
with other provider networks. Other direct costs of services increased
approximately $4.6 million, from $1.4 million in 1996 to $6.0 million in 1997.
Of this increase, approximately $3.4 million represented expenses of NHS and AHP
which were acquired effective October 1, 1996 and September 1, 1997,
respectively. The remainder of the increase was attributable to an overall
increase in expenses resulting primarily from a significant increase in the
number of employees to accommodate growth in the provider network business,
increased provider network development activities and the development of new
businesses. Excluding NHS and AHP employees, the Company employed 108 employees
at September 30, 1997, compared to 56 employees at September 30, 1996.

     General and administrative expenses increased approximately $848,000, from
approximately $711,000 in 1996 to approximately $1.6 million in 1997. Of this
increase, approximately $587,000 represented expenses of NHS and AHP. The
remainder of the increase was attributable to an overall increase in expenses
resulting from the addition of employees in the administrative and executive
areas, expenses related to bonus and other benefit programs which became
effective subsequent to the initial public offering and an increase in
professional fees for accounting and legal services.

     Depreciation and amortization increased approximately $344,000 from
approximately $87,000 in 1996 to approximately $431,000 in 1997. The increase
was primarily attributable to the depreciation expense and amortization of
goodwill of NHS and AHP.

                                        7

<PAGE>



Nine Months Ended September 30, 1997 Compared to Nine Months Ended
September 30, 1996

     Provider network revenue increased by $4.9 million, from $23.0 million in
1996 to $27.9 million in 1997. Of this increase, $3.9 million was attributable
to the addition of new Payor Clients, the growth in the overall claims volume
from existing Payor Clients and the expansion of the Company's provider network.
The remainder of the increase was attributable to the acquisition of AHP. At
September 30, 1997 the provider network consisted of approximately 5,600
Contracting Providers compared to approximately 1,900 Contracting Providers at
September 30, 1996. Utilization management services revenue of $14.7 million in
1997 represents the revenue of NHS which was acquired effective October 1, 1996.

     Direct contract expenses increased by $11.0 million, from $9.3 million in
1996 to $20.3 million in 1997. Access fees to other provider networks as a
percentage of provider network revenue were 18.9% ($4.4 million) in 1996
compared to 12.4% ($3.4 million) in 1997. This decrease was attributable to the
growth in the number of providers contracting directly with UP&UP, Payor Clients
accessing more direct contracts and the negotiation of lower rates in agreements
with other provider networks. Other direct costs of services increased
approximately $12.0 million, from $4.0 million in 1996 to $16.0 million in 1997.
Of this increase, approximately $9.5 million represented expenses of NHS and AHP
which were acquired effective October 1, 1996 and September 1, 1997,
respectively. The remainder of the increase was attributable to an overall
increase in expenses resulting primarily from a significant increase in the
number of employees to accommodate growth in the provider network business,
increased provider network development activities and the development of new
businesses. Excluding NHS and AHP employees, the Company employed 108 employees
at September 30, 1997, compared to 56 employees at September 30, 1996.

     General and administrative expenses increased approximately $3.2 million,
from approximately $1.4 million in 1996 to approximately $4.6 million in 1997.
Of this increase, approximately $1.6 million represented expenses of NHS and
AHP. The remainder of the increase was attributable to an overall increase in
expenses resulting from the addition of employees in the administrative and
executive areas, expenses related to bonus and other benefit programs which
became effective subsequent to the initial public offering and an increase in
professional fees for accounting and legal services.

     Depreciation and amortization increased approximately $859,000 from
approximately $229,000 in 1996 to approximately $1.1 million in 1997. The
increase was primarily attributable to the depreciation expense and amortization
of goodwill of NHS and AHP.

LIQUIDITY AND CAPITAL RESOURCES

     During the first six months of 1996, the Company financed its operations
principally through equity contributions. In July 1996, the Company completed
the sale to the public of 2,760,000 shares of the Company's common stock and
received proceeds (net of underwriters' commissions and expenses) of
approximately $26.9 million. At September 30, 1997 the Company had working
capital of approximately $19.2 million. In March 1997, the Company entered into
two lines of credit arrangements for loan commitments totaling $15 million. Of
this amount, $10 million was used for the purchase of AHP. The Company has also
entered into a $15 million term loan with the same bank, $10 million of which
will be used to replenish the amount drawn under the line of credit. In
addition, the Company has also received a standby commitment for an additional
$10 million.

     The Company's primary capital resources commitment is to fund advances to
contracting providers upon exercise of Prepayment Options granted to Contracting
Providers. Depending on increases in claims volume and in the number of
Contracting Providers and Payor Clients, the Company estimates that $2 million
to $4 million could be required to fund Prepayment Options during the remainder
of 1997. During June 1997, the Board of Directors of the Company approved a
common stock repurchase program of up to $5 million. As of September 30, 1997,
the Company had repurchased 173,550 shares of its outstanding common stock under
the program, at an aggregate purchase price of $2,357,843.



                                        8

<PAGE>



     The Company believes that its existing liquidity sources, anticipated funds
from operations, and credit arrangements will satisfy its cash requirements for
the next 30 months. However, in the event that the advances for Prepayment
Options exceeds the Company's currently anticipated estimates and/or other
available sources of liquidity to fund such payments are not as great as
anticipated, the Company could seek to borrow additional funds or obtain
additional infusions of equity to fund the balance of such advances.

IMPACT OF INFLATION

     Since the Company's revenues are based on medical costs, the impact of
inflation on operating costs and expenses should be offset by the impact of
inflation of medical costs.

CERTAIN FACTORS THAT MAY AFFECT FUTURE OPERATING RESULTS OR STOCK PRICES

     The Company's business is dependent on a variety of factors, including its
ability to enter into contracts with payors and providers on terms attractive to
all parties and the absence of substantial changes in the health care industry
that would diminish the need for the services offered by the Company.

     A significant portion of the Company's revenue is derived from a small
number of Payor Clients and state governments. The duration of the Company's
contracts with its Payor Clients and state governments are generally for a one
to two-year period, with automatic renewals on the anniversary date. However,
certain contracts may be terminated by either party at any time, generally upon
90 days notice and at the convenience of the state governments. Such contracts
are also subject to fee negotiations and revisions on an annual basis. There can
be no assurance that any of the Company's contracts with Payor Clients will not
be terminated early or will be renewed, and, if renewed, will contain favorable
terms. The loss of a contract with a major Payor Client and the inability to
replace any such client with significant new clients could have a material
adverse effect on the Company's business, financial condition or results of
operations. During October 1996, Wellpoint Health Networks, Inc. announced the
acquisition of the health insurance business of one of the Company's clients,
John Hancock Mutual Life Insurance Company. During May 1997, Conseco, Inc.
completed its merger with Pioneer Financial Services, Inc., also one of the
Company's clients. The Company has not been advised of and does not anticipate
any changes, at least in the short term, in its contracts with these clients.

     The Company's standard contract with a Contracting Provider includes a
one-year term, renewable automatically for successive one-year terms, unless the
Contracting Provider gives written notice of termination, typically at least 90
days prior to the renewal date. These contracts are also subject to negotiation
and revisions on an annual basis with respect to the level and amount of price
concessions for medical services. The termination of a significant number of
contracts with Contracting Providers having a high volume of claims with the
Company's Payor Clients, the inability to replace such contracts with contracts
with similar Contracting Providers and/or the renegotiation of contracts
resulting in reduced price concessions could have a material adverse effect on
the Company. A number of health care providers and/or hospital systems are
merging with or acquiring other hospitals or hospital systems to create large
integrated delivery systems. The formation of these delivery systems may impact
the future ability of the Company to contract directly with the individual
hospital facilities or obtain price concessions at the same level currently
obtained.

     Certain interest groups within the health care industry have expressed
concern with certain activities of entities that have been referred to as
"Silent PPOs." The Company understands that some provider-sponsored professional
or trade associations may be considering a legal challenge against one or more
such organizations, and that regulatory agencies in certain states may be
investigating the activities of such organizations. Although it is unclear what
legal theories would support such a challenge or warrant such an investigation,
there can be no assurance that the Company would not be a target of such
challenge or investigation.

     The potential impact of all of the above factors is difficult for the
Company to forecast, and these or other factors, such as sales of substantial
amounts of the Company's Common Stock in the public market, the Company's common
stock repurchase program, and changes in earnings estimates by securities
analysts, can materially affect the Company's operating results and stock price.
Further, in recent years, the stock market has experienced extreme price and
volume fluctuations that have particularly affected the market prices of
securities of many companies, for reasons frequently

                                        9

<PAGE>



unrelated to the performance of the specific companies. These fluctuations, as
well as general economic, political and market conditions, may materially
adversely affect the market price of the Company's Common Stock. There can be no
assurances that the trading price of the Company's Common Stock will remain at
or near its current level.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

     Neither the Company nor its subsidiaries are involved in any pending legal
proceedings, other than routine legal matters occurring in the ordinary course
of business, which in the aggregate involve amounts which are believed by
management to be immaterial to the consolidated financial condition or results
of operations of the Company, except as referenced in Note 2 to the Consolidated
Financial Statements for the three and nine months ended September 30, 1997.

ITEM 2. CHANGES IN SECURITIES (Not Applicable)

ITEM 3. DEFAULTS UPON SENIOR SECURITIES (Not Applicable)

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     The annual meeting of the stockholders of the Company was held on June 3,
1997. The following matters were submitted to a vote of the stockholders:

1. The following individuals were elected to the Board of Directors for a
three-year term with the indicated votes:

<TABLE>
<CAPTION>
                                        For         Against     Abstain
                                    ----------      -------     -------
          <S>                       <C>              <C>         <C>
          William E. Brock          10,901,856       2,550       None
          Edward S. Civera          10,901,856       2,550       None
          David J. Drury            10,901,856       2,550       None
</TABLE>

     The following individual was elected to the Board of Directors for a
one-year term with the indicated votes:

<TABLE>
<CAPTION>
                                        For         Against     Abstain
                                    ----------      -------     -------
          <S>                       <C>              <C>         <C>
          Kenneth J. Linde          10,901,706       2,700       None
</TABLE>

     Board members whose term of office continued after the meeting are as
follows:

          Bette B. Anderson
          Thomas L. Blair
          Frederick H. Graefe
          Thomas J. Graf
          Julia Lawler

2.   The adoption of the Company's 1996 Employee Stock Purchase Plan was
     approved by a count of 10,611,489 affirmative votes, 16,600 negative votes
     and 6,390 abstentions.

3.   The adoption of the Company's 1996 Stock Option Plan was approved by a
     count of 8,948,779 affirmative votes, 1,666,610 negative votes and 7,690
     abstentions.

4.   The appointment of Coopers & Lybrand L.L.P. as independent auditors of the
     Company was ratified by a count of 10,791,266 affirmative votes, 950
     negative votes and 4,790 abstentions.

     There were 269,927 and 281,327 broker non-votes with respect to the
adoption of the Company's 1996 Employee Stock Purchase Plan and the 1996 Stock
Option Plan, respectively.

                                       10

<PAGE>



ITEM 5. OTHER INFORMATION (None)

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

1. The following exhibits are filed as part of this report unless noted
otherwise:

  Exhibit No.                          Description

     2.1      Agreement with America's Health Plan, Inc. (1)
     2.2      Plan and Agreement of Merger of IM&I, Inc. into PB Newco (1)
     2.3      Plan and Agreement of Merger of PB Newco, Inc. into United Payors
              & United Providers, Inc. (1)
     3.1      Certificate of Incorporation of United Payors & United Providers,
              Inc. (1)
     3.2      Bylaws of United Payors & United Providers, Inc. (1)
     4.1      Specimen Stock Certificate of United Payors & United Providers,
              Inc. (1)
     4.2      Shareholder Agreement (1)
     10.1     Employment Agreement between United Payors & United Providers,
              Inc. and Thomas L. Blair (1)
     10.2     Employment Agreements between United Payors & United Providers,
              Inc. and each of Spiro A. Karadimas, S. Joseph Bruno and Michael
              A. Smith (1)
     10.3     Form of Indemnification Agreement (1)
     10.4     Stock Purchase Agreement between Preferred Health Choice and
              United Payors & United Providers, Inc. dated October 22, 1996 (2)
     10.5     Warrants to Purchase 150,000 Shares of Common Stock of United
              Payors & United Providers, Inc. Issued to Preferred Health Choice,
              Inc. dated October 23, 1996 (3)
     10.6     Warrants to Purchase 168,000 Shares of Common Stock of United
              Payors & United Providers, Inc. Issued to Preferred Health Choice,
              Inc. dated October 27, 1996 (3)
     10.7     Stock Purchase Agreement between United Payors & United Providers,
              Inc. and Principal Holding Company, a wholly-owned subsidiary of
              Principal Mutual Life Insurance Company, dated September 29,
              1997 (4)
     11.1     Statement Regarding Computation of Earnings Per Common Share --
              Three Months
     11.2     Statement Regarding Computation of Earnings Per Common Share --
              Nine months
     27.1     Financial Data Schedule
- --------------
(1)  Incorporated herein by reference into this document from the Exhibits to
     the Form S-1 Registration Statement, as amended, Registration No. 333-3814,
     initially filed on April 19, 1996.
(2)  Incorporated herein by reference into this document from the Exhibits to
     the Form 10-Q for the quarter ended September 30, 1996.
(3)  Incorporated herein by reference into this document from the Exhibits A-1
     and A-2 to the Stock Purchase Agreement filed as Exhibit 10.4 to the Form
     10-Q for the quarter ended September 30, 1996.
(4)  Incorporated herein by reference into this document from the Exhibits to
     the Form 8-K dated October 13, 1997.

2.   Reports on Form 8-K

     The Company filed a Current Report on Form 8-K dated October 13, 1997
reporting Items 2 and 7 in connection with the Company's acquisition of UP&UP,
Inc. (formerly America's Health Plan, Inc.). The following financial statements
and pro forma financial information were filed:

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Balance Sheets as of
     December 31, 1996 and 1995.

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Statements of
     Operations for the Years Ended December 31, 1996 and 1995.

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Statements of
     Stockholder's Equity for the Years Ended December 31, 1996 and 1995.

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Statements of Cash
     Flows for the Years Ended December 31, 1996 and 1995.

                                       11

<PAGE>



     Notes to Financial Statements.

     Report of Independent Auditors.

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Unaudited June 30, 1997
     Balance Sheet.

     UP&UP, Inc. (formerly America's Health Plan, Inc.) Unaudited Statements of
     Operations and Cash Flows for the Six Months Ended June 30, 1997 and 1996.

     Notes to the Unaudited June 30, 1997 Financial Statements.

     Unaudited Pro Forma Consolidated Balance Sheet as of June 30, 1997.

     Unaudited Pro Forma Consolidated Statements of Operations for the Six
     Months Ended June 30, 1997 and the Year Ended December 31, 1996.

     Notes to Unaudited Pro Forma Consolidated Financial Statements.




                                       12

<PAGE>



                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                     UNITED PAYORS & UNITED PROVIDERS, INC.
                                                   (Registrant)


Date: November 13, 1997       By:    /s/   THOMAS L. BLAIR
                                     --------------------------------------
                                     Thomas L. Blair
                                     Chairman and Chief Executive Officer



Date: November 13, 1997       By:    /s/   EDWARD S. CIVERA
                                     --------------------------------------
                                     Edward S. Civera
                                     President and Chief Operating Officer



Date: November 13, 1997       By:    /s/   S. JOSEPH BRUNO
                                     --------------------------------------
                                     S. Joseph Bruno
                                     Vice President and Chief Financial Officer



Date: November 13, 1997       By:    /s/   EDUARDO V. FEITO
                                     --------------------------------------
                                     Eduardo V. Feito
                                     Controller and Chief Accounting Officer



                                       13

<PAGE>

EXHIBIT 11.1

                     UNITED PAYORS & UNITED PROVIDERS, INC.
                                AND SUBSIDIARIES
                    COMPUTATION OF EARNINGS PER COMMON SHARE
                                   (Unaudited)


<TABLE>
<CAPTION>
                                                            Three Months Ended September 30,
                                                                 1997             1996
                                                            --------------   --------------
<S>                                                           <C>            <C>
                                         PRIMARY

Net income                                                    $  3,978,553   $  2,601,979
                                                              ============   ============

Weighted average number of common shares outstanding:
   Shares outstanding from beginning of period                  11,526,786      8,800,000
   Other issuances of common stock                                      --      2,535,205
   Purchases of treasury stock                                     (63,261)          (897)
   Common stock equivalents:
Additional equivalent shares issuable from assumed
       exercise of common stock options                            320,237             --
                                                              ------------   ------------

Weighted average common and common share equivalents            11,783,762     11,334,308
                                                              ============   ============

Net income per common share                                   $       0.34   $       0.22
                                                              ============   ============



                                       FULLY DILUTED

Net income                                                    $  3,978,553   $  2,601,979
                                                              ============   ============

Weighted average number of common shares outstanding:
   Shares outstanding from beginning of period                  11,526,786      8,800,000
   Other issuances of common stock                                      --      2,535,205
   Purchases of treasury stock                                     (63,261)          (897)
   Common stock equivalents:
Additional equivalent shares issuable from assumed
   exercise of common stock options                                459,164             --
                                                              ------------   ------------

Weighted average common and common share equivalents            11,922,689     11,334,308
                                                              ============   ============

Net income per common share                                   $       0.33   $       0.22
                                                              ============   ============
</TABLE>





                                       14

<PAGE>


EXHIBIT 11.2

                     UNITED PAYORS & UNITED PROVIDERS, INC.
                                AND SUBSIDIARIES
                    COMPUTATION OF EARNINGS PER COMMON SHARE
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                            Nine Months Ended September 30,
                                                                 1997            1996
                                                            --------------   -------------
<S>                                                           <C>            <C>
                                       PRIMARY

Net income                                                    $ 10,789,461   $ 7,611,449
                                                              ============   ===========

Weighted average number of common shares outstanding:
   Shares outstanding from beginning of period                  11,551,136     8,800,000
   Other issuances of common stock                                  13,802       851,241
   Purchases of treasury stock                                     (38,453)         (301)
   Common stock equivalents:
Additional equivalent shares issuable from assumed
   exercise of common stock options                                157,097            --
                                                              ------------   -----------

Weighted average common and common share equivalents            11,683,582     9,650,940
                                                              ============   ===========

Net income per common share                                   $       0.92   $      0.79
                                                              ============   ===========



                                     FULLY DILUTED

Net income                                                    $ 10,789,461   $ 7,611,449
                                                              ============   ===========

Weighted average number of common shares outstanding:
   Shares outstanding from beginning of period                  11,551,136     8,800,000
   Other issuances of common stock                                  13,802       851,241
   Purchases of treasury stock                                     (38,453)         (301)
   Common stock equivalents:
Additional equivalent shares issuable from assumed
   exercise of common stock options                                330,652            --
                                                              ------------   -----------

Weighted average common and common share equivalents            11,857,137     9,650,940
                                                              ============   ===========

Net income per common share                                   $       0.91   $      0.79
                                                              ============   ===========
</TABLE>




                                       15

<PAGE>

<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND STATEMENTS OF OPERATIONS OF UNITED PAYORS &
UNITED PROVIDERS, INC. AS OF AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                                     <C>
<PERIOD-TYPE>                           9-MOS
<FISCAL-YEAR-END>                                    DEC-31-1997
<PERIOD-START>                                       JAN-01-1997
<PERIOD-END>                                         SEP-30-1997
<CASH>                                                 7,513,131
<SECURITIES>                                          11,418,464
<RECEIVABLES>                                         10,939,768
<ALLOWANCES>                                                   0
<INVENTORY>                                                    0
<CURRENT-ASSETS>                                      30,560,630
<PP&E>                                                 5,112,657
<DEPRECIATION>                                         1,157,067
<TOTAL-ASSETS>                                        75,225,678
<CURRENT-LIABILITIES>                                 11,329,580
<BONDS>                                                8,145,760
                                          0
                                                    0
<COMMON>                                              33,515,798
<OTHER-SE>                                            20,724,540
<TOTAL-LIABILITY-AND-EQUITY>                          75,225,678
<SALES>                                                        0
<TOTAL-REVENUES>                                      42,580,418
<CGS>                                                          0
<TOTAL-COSTS>                                         25,962,119
<OTHER-EXPENSES>                                               0
<LOSS-PROVISION>                                               0
<INTEREST-EXPENSE>                                        21,908
<INCOME-PRETAX>                                       18,108,569
<INCOME-TAX>                                           7,319,108
<INCOME-CONTINUING>                                   10,789,461
<DISCONTINUED>                                                 0
<EXTRAORDINARY>                                                0
<CHANGES>                                                      0
<NET-INCOME>                                          10,789,461
<EPS-PRIMARY>                                               0.92
<EPS-DILUTED>                                                  0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission